Hair Loss Medications: The Complete Comparison Guide

Evidence-based comparison of every major hair loss treatment option

Who This Article Is For#

This article is for you if:

• You're comparing different hair loss treatment options
• You want to understand the evidence behind each medication
• You're deciding between multiple treatments your doctor recommended
• You want to know which treatment might work best for your situation
• You're considering switching treatments due to side effects

This article is NOT for you if:

• You've already found a treatment that's working for you
• You're looking for in-depth information on just one medication (see our individual guides)
• You're seeking non-medication treatments (procedures, devices, supplements)
• You want to start treatment without medical guidance

The Hair Loss Medication Landscape#

Before diving into comparisons, let's understand what's actually available.

FDA-Approved Treatments (USA)#

That's it—just two medications across three formulations. Everything else is "off-label," meaning the medication is approved for something else but used for hair loss based on evidence.

Common Off-Label Treatments#

How Hair Loss Medications Work#

Understanding mechanisms helps you make informed choices.

The Two Main Approaches#

1. DHT Blockers (5-Alpha Reductase Inhibitors)

• Target the hormone (DHT) that causes follicle miniaturization
• Include: Finasteride, dutasteride, topical finasteride
• Work systemically or locally to reduce DHT

2. Growth Stimulators

• Increase blood flow and prolong growth phase
• Include: Minoxidil (all forms)
• Don't address DHT—work independently

Mechanism Comparison#

Efficacy Ranking: What Works Best?#

A 2025 network meta-analysis provides the most comprehensive comparison to date.

SUCRA Rankings (Efficacy Scores)#

Improvement Rates at 12 Months#

All three rates below come from one trial: Hu et al. 2015, a 12-month randomized comparative study in 450 Chinese men assigned to finasteride 1 mg, topical minoxidil 5% or both, with efficacy evaluated in 428 men at 12 months (PMID 26031764).

Key Finding: In that trial, combination therapy outperformed either single treatment. Dutasteride and oral minoxidil were not arms in it, so no improvement rate is stated for them here; their standing against the others is the SUCRA ranking above, which is a percentile rather than a success rate.

DHT Reduction: The Numbers#

For DHT blockers, the degree of DHT reduction matters.

DHT Reduction Comparison#

What This Means#

• Dutasteride blocks about 20 percentage points more DHT than finasteride
• This translates to measurably better hair outcomes
• But also potentially more side effects
• Topical options minimize systemic DHT changes

Hair Count Data: Head-to-Head Results#

Clinical trial data shows actual hair changes.

Direct Comparison: Olsen 2006 and Shanshanwal 2017#

The four rows below come from one trial: Olsen 2006, a 24-week randomized, placebo-controlled study in 416 men aged 21 to 45 that compared dutasteride 0.05, 0.1, 0.5 and 2.5 mg daily against finasteride 5 mg daily and placebo, measured as change in target area hair count (PMID 17110217).

Finasteride 1 mg was not an arm in that trial, which is why it is absent from the table. The nearest head-to-head figure comes from a different study measured on a different scale: Shanshanwal 2017 (PMID 27549867), an open-label, evaluator-blinded randomized trial that recruited 90 men and ran 24 weeks, counted hairs in the target area by phototrichogram and reported them per cm², finding finasteride 1 mg went from 227 to 231 hairs/cm² (about +4) while dutasteride 0.5 mg went from 223 to 246 (about +23). Because those counts are normalized per cm² and the table above reports absolute counts across Olsen's fixed target area, the two sets of numbers are not on the same scale and should not be compared cell to cell.

Topical vs Oral Finasteride#

These figures come from Piraccini 2022 (PMID 34634163), a 24-week randomized, double-blind trial in 458 men that compared topical finasteride 0.25% spray against placebo and carried an oral finasteride 1 mg arm for comparison.

Key Finding: The trial calls the topical and oral hair counts "numerically similar" but does not publish the oral figure in its abstract, so no oral hair count is stated here. What it does publish is the exposure gap: topical finasteride cut serum DHT by 34.5% against oral's 55.6%, at maximum plasma concentrations more than 100 times lower.

Side Effect Comparison#

Every medication has trade-offs. Understanding side effects helps you choose wisely.

Sexual Side Effects (5-AR Inhibitors)#

Important Notes:

• Side effects often resolve spontaneously during continued treatment
• Some reports of persistent effects after stopping (controversial)
• Risk increases about 1.57-fold with any 5-AR inhibitor

Minoxidil Side Effects#

Other Treatment Side Effects#

Treatment Selection by Patient Profile#

Different patients need different approaches.

For Men with Androgenetic Alopecia#

Mild Hair Loss (Norwood 1-2)

• First-line: Topical minoxidil 5%
• Alternative: Finasteride 1mg if DHT blocking preferred
• Consider: Low-dose finasteride (0.5mg or 0.2mg daily)

Moderate Hair Loss (Norwood 3-4)

• First-line: Finasteride 1mg + topical minoxidil 5%
• Alternative: Dutasteride if finasteride response insufficient
• Consider: Topical finasteride if side effect concerns

Advanced Hair Loss (Norwood 5-7)

• First-line: Aggressive combination therapy
• Consider: Oral minoxidil 2.5-5mg for better coverage
• Alternative: Dutasteride 0.5mg if not responding to finasteride

For Women with Pattern Hair Loss#

Standard Approach

• First-line: Topical minoxidil 5%
• Second-line: Spironolactone 100-200mg daily
• Alternative: Low-dose oral minoxidil (0.625-2.5mg)

Pre-Menopausal Women

• Must use contraception if taking spironolactone
• Finasteride contraindicated (pregnancy risk)

Post-Menopausal Women

• Can consider finasteride off-label
• Spironolactone generally safe

Oral vs Topical: What's Better?#

Route of administration affects both efficacy and safety.

Oral Advantages#

• Better compliance (easier to remember)
• More consistent absorption
• Potentially more coverage for diffuse loss

Topical Advantages#

• Lower systemic exposure
• Fewer systemic side effects
• Can target specific areas

Evidence Summary#

Cost Considerations#

Price varies dramatically between treatments.

Approximate Monthly Costs (2025)#

Cost-Effectiveness Ranking#

1. Best Value: Generic oral finasteride + OTC minoxidil
2. Good Value: Generic dutasteride + OTC minoxidil
3. Moderate Value: Telehealth subscription services
4. Higher Cost: Compounded topical combinations

Combining Treatments: The Best Results#

Research consistently shows combination therapy wins.

Why Combinations Work Better#

Recommended Combinations#

Most Studied

• Oral finasteride 1mg + topical minoxidil 5% (twice daily)
• Evidence: 94.1% improvement vs 80.5% with finasteride alone at 12 months (Hu et al., 2015)

Maximum Convenience

• All-in-one oral: Finasteride 1mg + minoxidil 2.5mg daily
• Single pill, maximum compliance

Minimal Systemic Effects

• Topical combination: 0.25% finasteride + 5% minoxidil
• Single application, low systemic absorption

When to Consider Switching Treatments#

Sometimes your first choice isn't the best choice.

Signs You Might Need to Switch#

Switching Strategies#

From Finasteride to Dutasteride

• Can switch directly (no washout needed)
• Expect improved results if finasteride-responsive
• May see increased side effects

From Topical to Oral Minoxidil

• Can overlap during transition
• May see temporary shedding
• Better for diffuse thinning

Adding Treatments

• Generally safer than switching
• Addresses multiple mechanisms
• Better evidence for efficacy

Safety Updates and Warnings#

Stay informed about current safety information.

2025 Regulatory Updates#

Finasteride (EMA Update)

• European Medicines Agency updated labeling
• Added warning about suicidal ideation risk
• Requires patient counseling before prescription

Compounded Topical Finasteride (FDA Alert)

• FDA aware of adverse event reports
• Concerns about quality control in compounding
• Recommends using reputable pharmacies

Long-Term Safety Data#

Making Your Decision#

Here's how to approach your treatment choice.

Decision Framework#

Step 1: Assess Your Situation

• Sex (determines which options apply)
• Hair loss severity (guides aggressiveness)
• Side effect tolerance (oral vs topical)
• Budget (generic vs brand)

Step 2: Consider First-Line Options

• Men: Finasteride 1mg or topical minoxidil 5%
• Women: Topical minoxidil 5%

Step 3: Optimize Over Time

• No response at 6 months? Consider adding treatment
• Side effects? Try topical versions
• Partial response? Combine treatments

Step 4: Reassess Regularly

• Photo documentation monthly
• Treatment adjustment at 6-12 month intervals
• Consider escalation if progressing despite treatment

Frequently Asked Questions#

Related Resources#

• What Happens When You Stop Finasteride or Minoxidil
• How Long Until Hair Loss Treatment Works?
• Treatment Evidence Explorer

MHRA Safety Warning: Finasteride (11 May 2026)#

This is a difference between the drugs compared above, not a footnote to all of them. Minoxidil, topical or oral, carries no warning of this kind. Finasteride and dutasteride do, and any comparison that weighs efficacy without weighing this is comparing on one axis and presenting it as the whole answer.

On 11 May 2026 the UK Medicines and Healthcare products Regulatory Agency (MHRA) strengthened its safety warnings for finasteride and dutasteride [14]. Its stated position is that "finasteride is associated with depression, suicidal ideation and sexual dysfunction which may persist after treatment is stopped".

The MHRA's advice for people taking finasteride 1 mg — the dose used for hair loss — is to act, not to wait:

stop finasteride 1mg immediately if you develop depression or suicidal thoughts

Its advice to prescribers is to "inform patients of the risks at point of prescribing", to "review their medical record, ask patients if they have a history of depression or suicidal ideation", and that "patients prescribed finasteride 1 mg should stop taking the medicine if they develop suicidal thoughts or depression".

The reporting behind the change: "Yellow Card data since 1994 to 31 May 2025 includes 170 reports of suicidal ideation and related terms for finasteride (1mg and 5mg) and 5 reports for dutasteride 0.5mg. There were 19 fatal reports of suicide for finasteride" [14].

Two things belong next to those numbers. Yellow Card reports are spontaneous reports of a suspicion, not confirmed causes, and 170 reports across 31 years of a very widely prescribed drug is a small count against enormous exposure. And a regulator reviewed that evidence and strengthened its warnings anyway. Both of those are true, and a page that gives you only one of them is selling you something.

The MHRA advises that if you have seriously harmed yourself or feel you are at risk of serious harm, contact emergency services on 999 immediately. In the US, call or text 988 for the Suicide and Crisis Lifeline.